PracticeVideosBlogFlashcardsEspañol
All Practice Exams

Free Practice Questions for Sudan Medical Council Licensing Exam — Doctor

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
Exam pass rate: 92% (20–21 June 2026 doctors' sitting: 2,754 passed of 2,995 who sat); 85.9% in medicine at the 29–30 August 2026 sitting
100+ Questions
100% Free

Loading practice questions...

Exam Review

Key Facts: Sudan Medical Council Licensing Exam — Doctor Exam

200 Questions

Two 100-question computer-based papers across two sessions

SMC Examinee Guidelines 2025 (إرشادات للممتحنين 2025)

2 × 2 Hours

Two 2-hour sessions separated by a 20-minute supervised break

SMC Examinee Guidelines 2025 & May 2026 Session Schedule

6 Core Subjects

Paper 1: Pediatrics, Internal Medicine, Ethics; Paper 2: OB/GYN, Surgery, Community Medicine

SMC Examinee Guidelines 2025

92% Pass Rate

2,754 of 2,995 doctors passed in the 20–21 June 2026 sitting (86.5% in November 2025)

SMC 22 June 2026 Results Notice & SUNA Council Report

11 Sudan + Cairo

Examination centres operating in the June 2026 sitting (10 Sudan centres + Cairo in May 2026)

SMC / SUNA May & June 2026 Reports

Post-Internship

Requires SMC provisional registration and FMOH internship completion list clearance

SMC Licensing Exam Registration Portal (smcsdn.com)

The Sudan Medical Council (المجلس الطبي السوداني — SMC) Practice Licensing Examination (امتحان ممارسة المهنة) for doctors consists of two computer-based papers in two 2-hour sessions (200 questions in 4 hours total, with a 20-minute supervised break): Paper 1 covers Pediatrics, Internal Medicine, and Professional Ethics, and Paper 2 covers Obstetrics and Gynecology, Surgery, and Community Medicine. SMC does not publish per-subject question counts, a numerical pass mark, or the assessment language; in the 20–21 June 2026 sitting, 2,754 of 2,995 doctors passed (92%). OpenExamPrep provides 100 independent English-language MCQs weighted 50/50 across the two papers as a study aid, not official SMC items.

Sample Sudan Medical Council Licensing Exam — Doctor Practice Questions

Try these sample questions to review concepts for the Sudan Medical Council Licensing Exam — Doctor exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 26-year-old man in Wad Madani presents with a 2-day history of fever, chills, headache, and myalgia. He has no vomiting, normal mental status, and stable vital signs. A peripheral blood smear confirms uncomplicated Plasmodium falciparum malaria. According to the Sudan Federal Ministry of Health (FMOH) Malaria Case Management Protocol, what is the preferred first-line treatment and administration advice?
A.Oral artemether-lumefantrine as 6 doses over 3 days, each dose taken with fatty food or milk
B.Oral artesunate plus sulfadoxine-pyrimethamine given over 3 days on an empty stomach
C.Oral chloroquine phosphate given over 3 days followed by a 14-day course of primaquine
D.Intravenous quinine dihydrochloride infused in 5% dextrose every 8 hours for 7 days
Explanation: Sudan's FMOH Malaria Case Management Protocol (2023), which kept the 2017 first-line choice, uses oral artemether-lumefantrine (AL) for uncomplicated malaria: 6 doses over 3 days (at 0 and 8 hours, then twice daily on days 2 and 3). Lumefantrine is highly lipophilic, so taking each dose with fatty food or milk improves its absorption.
2A 34-year-old woman in Gedaref completed a full, directly observed 3-day course of oral artemether-lumefantrine for microscopically confirmed uncomplicated Plasmodium falciparum malaria 16 days ago. She returns with recurrent fever and a blood film showing asexual P. falciparum parasitemia, with no clinical or laboratory features of severe malaria. Under the Sudan FMOH malaria treatment protocol, what is the recommended second-line oral therapy?
A.Oral mefloquine monotherapy given as two split doses 6 hours apart
B.Oral dihydroartemisinin-piperaquine (DHAP) once daily for 3 days
C.Oral sulfadoxine-pyrimethamine as a single 3-tablet stat dose
D.Intramuscular artemether monotherapy for 5 days
Explanation: The Sudan Federal Ministry of Health (FMOH) designates oral dihydroartemisinin-piperaquine (DHAP) given once daily for 3 days as the second-line artemisinin-based combination therapy (ACT) for uncomplicated malaria, used for treatment failure or when artemether-lumefantrine is contraindicated or unavailable (Malaria Case Management Protocol 2023). Switching to a different partner drug (piperaquine) also gives a longer post-treatment prophylactic effect.
3A 60 kg adult man is admitted to the emergency department in Sennar with cerebral malaria (Glasgow Coma Scale 9/15) and a Plasmodium falciparum parasitemia of 8%. Intravenous artesunate is selected as first-line parenteral therapy. Using the WHO weight-based dose, what is the calculated individual dose and initial dosing schedule for this patient?
A.120 mg IV at 0 and 24 hours, then once daily until oral ACT can be tolerated
B.144 mg IV at 0, 12, and 24 hours, then once daily until oral ACT can be tolerated
C.180 mg IV at 0, 8, 16, and 24 hours, then once daily until oral ACT is tolerated
D.600 mg IV infused over 4 hours every 8 hours until oral therapy can be tolerated
Explanation: For adults and children weighing 20 kg or more with severe malaria, WHO recommends parenteral artesunate 2.4 mg/kg IV or IM at 0, 12, and 24 hours, then once daily until the patient can take a full 3-day course of oral ACT. For a 60 kg patient, 2.4 mg/kg × 60 kg = 144 mg per dose. Sudan's 2023 protocol makes parenteral artesunate first-line for severe malaria and gives a weight-band table that rounds doses to practical vial volumes.
4A 22-year-old farmer from southern Gedaref State presents with a 6-week history of prolonged fever, weight loss, epistaxis, marked hepatosplenomegaly, and pancytopenia. An rK39 rapid diagnostic test and lymph node aspirate confirm primary visceral leishmaniasis (kala-azar), and HIV serology is negative. He is eligible for every regimen. Under WHO's July 2026 updated treatment guideline for eastern Africa, which regimen is recommended for him?
A.Sodium stibogluconate plus paromomycin by daily injection for 17 days, with no role for miltefosine
B.Paromomycin injection plus oral miltefosine (allometric dosing) daily for 14 days
C.A single 10 mg/kg infusion of liposomal amphotericin B, as used for kala-azar in South Asia
D.Sodium stibogluconate monotherapy by daily injection for 30 days
Explanation: In July 2026 WHO issued its first SSG-free recommendation for primary visceral leishmaniasis in eastern Africa: paromomycin injection plus oral miltefosine for 14 days. It needs one daily injection instead of two and is less toxic than the older 17-day sodium stibogluconate (SSG) plus paromomycin combination. SSG-based treatment remains for patients who are not eligible for miltefosine, for example because of pregnancy, since miltefosine is teratogenic. National protocols, including Sudan's, are expected to adopt the change, so check the current FMOH guideline.
5A 38-year-old man with newly diagnosed smear-positive, drug-susceptible pulmonary tuberculosis is started on standard four-drug intensive-phase therapy (isoniazid, rifampicin, pyrazinamide, and ethambutol). Which vitamin should be co-prescribed to prevent a classic peripheral neuropathic adverse effect, and which drug in the regimen causes this deficiency?
A.Thiamine (vitamin B1) to prevent ethambutol-induced retrobulbar neuritis
B.Pyridoxine (vitamin B6) to prevent isoniazid-induced peripheral neuropathy
C.Cyanocobalamin (vitamin B12) to prevent rifampicin-induced subacute combined degeneration
D.Folic acid (vitamin B9) to prevent pyrazinamide-induced megaloblastic neuropathy
Explanation: Isoniazid inhibits pyridoxine phosphokinase and combines with pyridoxal 5'-phosphate to form hydrazones that are excreted in the urine, depleting active vitamin B6 required for synaptic GABA and myelin synthesis. Co-prescribing pyridoxine (vitamin B6, 10–25 mg/day for prophylaxis) prevents isoniazid-induced symmetrical distal sensory peripheral neuropathy, particularly in patients with diabetes, malnutrition, HIV, pregnancy, or chronic kidney disease.
6A 45-year-old man in his fifth week of intensive-phase anti-tuberculosis therapy (HRZE) presents with difficulty distinguishing red from green traffic signals and blurred central vision in both eyes. His liver transaminases and serum uric acid are within expected ranges. Which medication should be discontinued immediately?
A.Rifampicin
B.Pyrazinamide
C.Ethambutol
D.Isoniazid
Explanation: Ethambutol chelates zinc and copper in retinal ganglion cells and the optic nerve, causing dose- and duration-dependent retrobulbar optic neuritis. Early manifestations include loss of red-green color discrimination (dyschromatopsia), central scotoma, and reduced visual acuity; prompt discontinuation of ethambutol usually allows visual recovery.
7A 58-year-old man with hypertension and smoking history presents with 90 minutes of crushing retrosternal chest pain, diaphoresis, blood pressure of 84/52 mmHg, heart rate of 54 beats/min, clear lung fields, and elevated jugular venous pressure. A 12-lead ECG shows 3 mm ST-segment elevation in leads II, III, and aVF, with ST-segment elevation in right-sided lead V4R. In addition to urgent reperfusion, which medication must be strictly avoided in this patient?
A.Chewable non-enteric-coated aspirin 300 mg
B.Sublingual or intravenous nitroglycerin
C.Intravenous normal saline bolus
D.Clopidogrel 600 mg oral loading dose
Explanation: ST-segment elevation in leads II, III, and aVF with ST elevation in V4R coupled with the clinical triad of hypotension, clear lung fields, and elevated jugular venous pressure confirms an acute inferior STEMI complicated by right ventricular (RV) infarction due to proximal right coronary artery occlusion. Because the ischemic right ventricle is preload-dependent, venodilators and preload-reducing agents such as nitrates (nitroglycerin), diuretics, and opioids can precipitate profound, refractory cardiogenic shock and are contraindicated.
8A 64-year-old woman with ischemic cardiomyopathy and a left ventricular ejection fraction (LVEF) of 30% presents for outpatient optimization after an episode of decompensated heart failure. Which of the following medications relieves congestive symptoms by promoting natriuresis but has NOT been shown in randomized trials to independently reduce all-cause mortality in heart failure with reduced ejection fraction (HFrEF)?
A.Bisoprolol
B.Spironolactone
C.Furosemide
D.Dapagliflozin
Explanation: Loop diuretics such as furosemide are essential for rapid relief of dyspnea and peripheral or pulmonary edema in patients with volume overload, but they do not independently reduce mortality or reverse ventricular remodeling in HFrEF. By contrast, beta-blockers (bisoprolol, carvedilol, sustained-release metoprolol succinate), mineralocorticoid receptor antagonists (spironolactone, eplerenone), ACE inhibitors/ARBs/ARNIs, and SGLT2 inhibitors (dapagliflozin, empagliflozin) all confer proven survival benefits.
9A 68-year-old man with non-valvular persistent atrial fibrillation attends the medical clinic. He has a history of treated hypertension and type 2 diabetes mellitus, and had a transient ischemic attack (TIA) 1 year ago. He has no history of heart failure or vascular disease. What is his CHA2DS2-VASc score, and what is the appropriate antithrombotic management?
A.Score 3; start low-dose aspirin monotherapy (81 mg daily)
B.Score 4; start long-term oral anticoagulation (a direct oral anticoagulant or warfarin with target INR 2.0–3.0)
C.Score 5; start long-term oral anticoagulation (a direct oral anticoagulant or warfarin with target INR 2.0–3.0)
D.Score 6; start dual antiplatelet therapy with aspirin and clopidogrel only
Explanation: On the CHA2DS2-VASc scale, the patient receives 1 point for Hypertension, 1 point for age 65–74 years, 1 point for Diabetes mellitus, and 2 points for prior Stroke/TIA/thromboembolism (0 points for male sex, no heart failure, and no vascular disease), giving a total score of 1 + 1 + 1 + 2 = 5. A CHA2DS2-VASc score of 2 or more in men (or 3 or more in women) is a strong indication for long-term oral anticoagulation with a DOAC (apixaban, rivaroxaban, dabigatran) or vitamin K antagonist (warfarin, target INR 2.0–3.0).
10A 19-year-old woman with type 1 diabetes mellitus presents with polyuria, vomiting, abdominal pain, and Kussmaul breathing. Laboratory findings show blood glucose 28 mmol/L (504 mg/dL), arterial pH 7.12, serum bicarbonate 8 mEq/L, positive serum ketones, and serum potassium 2.9 mmol/L. After initiating intravenous 0.9% sodium chloride resuscitation, what is the correct immediate step regarding insulin and potassium?
A.Start an immediate intravenous regular insulin bolus and infusion, and recheck potassium in 4 hours
B.Hold the insulin and give intravenous potassium until serum potassium reaches at least 3.3 mmol/L
C.Administer intravenous sodium bicarbonate first to raise arterial pH above 7.35, then start insulin
D.Administer subcutaneous long-acting glargine insulin only and give oral potassium tablets
Explanation: Although patients with diabetic ketoacidosis (DKA) have a severe total-body potassium deficit, insulin drives potassium rapidly into cells and will precipitate lethal hypokalemic cardiac arrhythmias and respiratory muscle paralysis if started when serum potassium is below 3.3 mmol/L. When initial serum potassium is <3.3 mmol/L, intravenous insulin must be withheld while isotonic fluid resuscitation and IV potassium chloride replacement (20–40 mmol/hr) are administered until serum potassium reaches >=3.3 mmol/L.

About the Sudan Medical Council Licensing Exam — Doctor Exam

The Sudan Medical Council (المجلس الطبي السوداني — SMC) Practice Licensing Examination (امتحان ممارسة المهنة, formerly called the Permanent Registration Examination / امتحان التسجيل الدائم) is the national computer-based licensing assessment required of provisionally registered medical graduates who have completed their internship (فترة الامتياز) to obtain full registration to practise medicine independently in the Republic of the Sudan. Under SMC's published examinee guidelines, the doctors' examination comprises two 2-hour, 100-question papers separated by a 20-minute supervised break: Paper 1 tests Pediatrics, Internal Medicine, and Professional Ethics, while Paper 2 tests Obstetrics and Gynecology, Surgery, and Community Medicine. Independent English-language MCQ practice by OpenExamPrep helps candidates review these six published areas, including SMC's Physician Charter and Sudan FMOH/WHO clinical and public-health protocols; these questions are an independent study aid and not official SMC items.

Exam sponsor: Sudan Medical Council (المجلس الطبي السوداني — SMC). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Sudan Medical Council (المجلس الطبي السوداني — SMC) administers the computer-based Practice Licensing Examination (امتحان ممارسة المهنة, formerly امتحان التسجيل الدائم) in two sessions on the same sitting day: Session 1 (Paper 1, 100 questions, 2 hours) covers Pediatrics (طب الأطفال), Internal Medicine (الطب الباطن), and Professional Ethics (أخلاقيات المهنة); after a 20-minute supervised break inside the examination hall, Session 2 (Paper 2, 100 questions, 2 hours) covers Obstetrics and Gynecology (النساء والتوليد), Surgery (الجراحة), and Community Medicine (طب المجتمع). SMC's May 2026 schedule runs 4-hour medicine blocks (07:00–11:00 and 12:00–16:00 Sudan time), distinct from the single 2-hour, 100-question paper for dentists and pharmacists. Because SMC does not publish per-subject item counts, the percentages below show this 100-question study bank's local distribution (50 questions per paper) rather than official SMC weights.

Time Limit

4 hours (two 2-hour papers separated by a 20-minute supervised break)

Passing Score

Not published

Exam / Certification Fees

Not published as a fixed amount (SMC announces fee payment for each sitting; the financial payment receipt is required for exam-hall entry)

Exam sponsor website

Reported exam pass rate: 92% (20–21 June 2026 doctors' sitting: 2,754 passed of 2,995 who sat); 85.9% in medicine at the 29–30 August 2026 sitting. In the 20–21 June 2026 doctors' sitting across 11 centres in Sudan plus Cairo, 3,117 candidates registered, 2,995 sat, and 2,754 passed (92%; SMC results notice of 22 June 2026 and Al Arabiya Sudan report of 23 June 2026). At the 29–30 August 2026 sitting (seven centres in Sudan plus Cairo), SMC's results statement, as reported in the Sudanese press on 3 September 2026, gave a pass rate of 85.9% in medicine. In the 8–9 November 2025 sitting, the pass rate in medicine was 86.5% (SMC council meeting reported by SUNA). This describes exam candidates, not OpenExamPrep users or results from using our resources. Exam sponsor website

Fees, eligibility, and exam policies can change. Confirm them with the exam sponsor before applying or paying.

Official sources

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

Paper 1 (per-subject count not published by SMC; 21% of this study bank)

Paper 1: Internal Medicine (الطب الباطن)

Cardiovascular, respiratory, endocrine, renal, hepatobiliary, hematologic, neurologic, and infectious/tropical medicine. Malaria follows the Sudan FMOH Malaria Case Management Protocol 2023 (artemether-lumefantrine first-line, dihydroartemisinin-piperaquine second-line, parenteral artesunate for severe disease). Visceral leishmaniasis follows WHO's July 2026 eastern Africa update (14-day paromomycin plus miltefosine for eligible patients; sodium stibogluconate plus paromomycin for those who cannot take miltefosine).

Paper 1 (per-subject count not published by SMC; 21% of this study bank)

Paper 1: Pediatrics and Child Health (طب الأطفال / طب وصحة الطفل)

Neonatal care and resuscitation, child growth and developmental milestones, the Sudan Expanded Programme on Immunization (EPI) schedule, IMCI classification, WHO dehydration management (Plans A, B, and C), severe acute malnutrition (SAM) stabilization and ReSoMal use, and common pediatric infections and emergencies.

Paper 1 (per-subject count not published by SMC; 8% of this study bank)

Paper 1: Professional Ethics and Medical Professionalism (أخلاقيات المهنة)

SMC's published Professionalism & Ethics page: the three fundamental principles of the Physician Charter (primacy of patient welfare, patient autonomy, and social justice), the professional commitments that serve them (competence, honesty with patients, confidentiality, appropriate relations with patients, quality of and access to care, just distribution of finite resources, scientific knowledge, managing conflicts of interest, and professional responsibilities), the marks of a profession, the implicit and evolving social contract between medicine and society, and the move from provisional to permanent registration.

Paper 2 (per-subject count not published by SMC; 17% of this study bank)

Paper 2: Obstetrics and Gynecology (النساء والتوليد)

Antenatal care and screening, malaria treatment in pregnancy, preeclampsia and eclampsia management (Pritchard and Zuspan magnesium sulfate protocols and toxicity management), normal and obstructed labor, active management of the third stage of labor, antepartum and postpartum hemorrhage, puerperal sepsis, ectopic pregnancy, contraception, and gynecologic conditions.

Paper 2 (per-subject count not published by SMC; 17% of this study bank)

Paper 2: General Surgery (الجراحة)

Trauma resuscitation (ATLS primary survey, tension pneumothorax, hemorrhagic shock), burn fluid resuscitation (Parkland formula), acute abdomen (appendicitis, acute cholecystitis, cholangitis, small and large bowel obstruction, perforated peptic ulcer), abdominal wall hernias, thyroid and breast disorders, acute urinary retention and testicular torsion, and perioperative surgical care.

Paper 2 (per-subject count not published by SMC; 16% of this study bank)

Paper 2: Community Medicine and Public Health (طب المجتمع)

Epidemiologic study designs, incidence and prevalence, relative risk, odds ratio, attributable risk, screening test metrics (sensitivity, specificity, PPV, NPV), biostatistics, communicable disease control and outbreak investigation in Sudan (cholera, meningococcal meningitis, yellow fever, schistosomiasis), maternal and child mortality indicators, and water and sanitation.

Preparing for the Sudan Medical Council Licensing Exam — Doctor Exam

What You Need to Know

  • Passing score: Not published
  • Assessment: The Sudan Medical Council (المجلس الطبي السوداني — SMC) administers the computer-based Practice Licensing Examination (امتحان ممارسة المهنة, formerly امتحان التسجيل الدائم) in two sessions on the same sitting day: Session 1 (Paper 1, 100 questions, 2 hours) covers Pediatrics (طب الأطفال), Internal Medicine (الطب الباطن), and Professional Ethics (أخلاقيات المهنة); after a 20-minute supervised break inside the examination hall, Session 2 (Paper 2, 100 questions, 2 hours) covers Obstetrics and Gynecology (النساء والتوليد), Surgery (الجراحة), and Community Medicine (طب المجتمع). SMC's May 2026 schedule runs 4-hour medicine blocks (07:00–11:00 and 12:00–16:00 Sudan time), distinct from the single 2-hour, 100-question paper for dentists and pharmacists. Because SMC does not publish per-subject item counts, the percentages below show this 100-question study bank's local distribution (50 questions per paper) rather than official SMC weights.
  • Time limit: 4 hours (two 2-hour papers separated by a 20-minute supervised break)
  • Exam / certification fees: Not published as a fixed amount (SMC announces fee payment for each sitting; the financial payment receipt is required for exam-hall entry) Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Sudan Medical Council Licensing Exam — Doctor: Suggested Study Strategy

1Pace yourself for two consecutive 100-question, 2-hour papers (1.2 minutes per question) separated only by a 20-minute supervised break inside the exam hall where phones and study notes are not permitted.
2Organize your revision by paper: group Internal Medicine, Pediatrics, and Professional Ethics together for Paper 1, and group Obstetrics and Gynecology, General Surgery, and Community Medicine together for Paper 2.
3For Internal Medicine and Pediatrics, review Sudan Federal Ministry of Health (FMOH) and WHO protocols: the 2023 malaria case management protocol (artemether-lumefantrine first-line, dihydroartemisinin-piperaquine second-line, parenteral artesunate for severe malaria, artemether-lumefantrine in all trimesters of pregnancy), WHO's July 2026 kala-azar update for eastern Africa, the Sudan EPI schedule, and IMCI/SAM stabilization.
4Review SMC's Professionalism & Ethics page (A Physician Charter): learn the three fundamental principles (primacy of patient welfare, patient autonomy, and social justice), the professional commitments that serve them, the marks of a profession, and the expectations of medicine and society under the social contract.
5For Paper 2, drill high-yield surgical and obstetric emergencies (ATLS primary survey, Parkland burn resuscitation, acute abdomen, active management of the third stage of labor, postpartum hemorrhage, and magnesium sulfate regimens for eclampsia) alongside epidemiological 2×2 table calculations (sensitivity, specificity, PPV, NPV, relative risk, odds ratio, and attributable risk).

Frequently Asked Questions

What is the structure of the Sudan Medical Council (SMC) licensing exam for doctors?

According to the Sudan Medical Council's examinee guidance (إرشادات للممتحنين 2025), the doctors' Practice Licensing Examination (امتحان ممارسة المهنة, formerly امتحان التسجيل الدائم) is a computer-based MCQ exam consisting of two papers across two sessions on the same day. Paper 1 has 100 questions in 2 hours covering Pediatrics (طب الأطفال), Internal Medicine (الطب الباطن), and Professional Ethics (أخلاقيات المهنة). After a 20-minute supervised break inside the exam hall, Paper 2 has 100 questions in 2 hours covering Obstetrics and Gynecology (النساء والتوليد), Surgery (الجراحة), and Community Medicine (طب المجتمع).

Does the Sudan Medical Council publish exact question counts per subject or a numerical pass mark?

No. SMC publishes the total of 100 questions per 2-hour paper (200 questions total) and specifies which three subjects appear in Paper 1 and Paper 2, but it does not publish per-subject question counts or a numerical passing percentage. In this OpenExamPrep bank, the 100 practice questions are split 50/50 between Paper 1 and Paper 2 subjects as a local study allocation, not as official SMC weights.

Who is eligible to sit the SMC Practice Licensing Examination, and how do candidates register?

Medical graduates from Sudanese and recognized foreign universities who hold provisional registration (التسجيل التمهيدي) with the Sudan Medical Council and whose names appear on the internship-completion lists (فترة الامتياز) sent by the Federal Ministry of Health are eligible. Candidates apply through the 'Licensing Exam Registration' page on smcsdn.com, entering their SMC registration number, name, registration type, and provisional registration date during the registration window announced for each sitting, then pay the exam fee as that sitting's notice instructs. In November 2025, the Council decided that the medical oath (القسم الطبي) is taken at the end of internship, when sitting this exam.

What documents are required on exam day, and what are the hall rules?

Under SMC's examinee instructions, candidates must arrive one hour before the session according to the announced lists and present three mandatory items to enter the hall: (1) the exam form showing the candidate's username and password, (2) a valid original passport or national ID card (بطاقة قومية), and (3) the financial payment receipt (الإيصال المالي لتسديد الرسوم). No candidate is admitted after the exam starts, and bringing a mobile phone or any electronic communication device into the hall is strictly prohibited and recorded as a cheating violation.

Where were the 2026 SMC licensing exam sittings held, and what was the pass rate?

In 2026, SMC held sittings in January; on 9–10 May (10 centres in Sudan—Port Sudan at National University, Atbara, Shendi, Berber, Dongola, Kassala, Kosti, Gedaref, El Obeid, and National University in Khartoum—plus Cairo, with about 3,565 doctors, pharmacists, and dentists expected); on 20–21 June (11 centres in Sudan plus Cairo); and on 29–30 August (seven centres in Sudan plus Cairo). In the 20–21 June 2026 doctors' sitting, 3,117 registered, 2,995 sat, and 2,754 passed (92%). The August 2026 medicine pass rate was reported as 85.9%, and the November 2025 medicine pass rate was 86.5%. Check SMC's official channels for the next sitting.

In what language is the SMC exam delivered, and are these official SMC questions?

SMC's published examinee notices do not specify the assessment language. The questions on this page are an independent English-language MCQ study adaptation written by OpenExamPrep to help candidates review the six published Paper 1 and Paper 2 subjects. They are not official SMC items, an official translation, or a simulation of the examination.